{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T12:41:32Z","timestamp":1779108092244,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T00:00:00Z","timestamp":1718236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03557-7","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T10:03:36Z","timestamp":1718273016000},"page":"3246-3251","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Stereotactic ablative radiotherapy (SABR) for patients with lung tumor and severe pulmonary function impairment"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5185-5653","authenticated-orcid":false,"given":"Abraham Andr\u00e9 Arturo","family":"Geng-Cahuayme","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Peregr\u00edn-Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Ramos-Albiac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5269-2246","authenticated-orcid":false,"given":"Enar","family":"Recalde-Vizcay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Sebasti\u00e1n","family":"Parada-Zuluaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1840-5159","authenticated-orcid":false,"given":"Jordi","family":"Giralt-L\u00f3pez de Sagredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2045-4723","authenticated-orcid":false,"given":"Xavier","family":"Maldonado-Pijoan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7484-9715","authenticated-orcid":false,"given":"Alexandra","family":"Giraldo-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,6,13]]},"reference":[{"issue":"5","key":"3557_CR1","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1378\/chest.129.5.1305","volume":"129","author":"RS Loganathan","year":"2006","unstructured":"Loganathan RS, Stover DE, Shi W, Venkatraman E. Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer. Chest. 2006;129(5):1305\u201312. https:\/\/doi.org\/10.1378\/chest.129.5.1305.","journal-title":"Chest"},{"issue":"1","key":"3557_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.lungcan.2005.01.001","volume":"49","author":"R Rami-Porta","year":"2005","unstructured":"Rami-Porta R, Wittekind C, Goldstraw P, International Association for the Study of Lung Cancer (IASLC) Staging Committee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer. 2005;49(1):25\u201333. https:\/\/doi.org\/10.1016\/j.lungcan.2005.01.001.","journal-title":"Lung Cancer"},{"issue":"3","key":"3557_CR3","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1093\/jrr\/rraa015","volume":"61","author":"H Onishi","year":"2020","unstructured":"Onishi H, Shioyama Y, Matsumoto Y, et al. Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity. J Radiat Res. 2020;61(3):426\u201330. https:\/\/doi.org\/10.1093\/jrr\/rraa015.","journal-title":"J Radiat Res"},{"issue":"17","key":"3557_CR4","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1016\/j.ejca.2014.09.006","volume":"50","author":"Y Matsuo","year":"2014","unstructured":"Matsuo Y, Chen F, Hamaji M, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer. 2014;50(17):2932\u20138. https:\/\/doi.org\/10.1016\/j.ejca.2014.09.006.","journal-title":"Eur J Cancer"},{"issue":"6","key":"3557_CR5","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang JY, Senan S, Paul MA, et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015;16(6):630\u20137. https:\/\/doi.org\/10.1016\/S1470-2045(15)70168-3.","journal-title":"Lancet Oncol"},{"issue":"5","key":"3557_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ijrobp.2015.07.2278","volume":"93","author":"Y Nagata","year":"2015","unstructured":"Nagata Y, Hiraoka M, Shibata T, et al. Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan clinical oncology group study JCOG0403. Int J Radiat Oncol Biol Phys. 2015;93(5):989\u201396. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.07.2278.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"3557_CR7","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1097\/JTO.0000000000000525","volume":"10","author":"Y Shibamoto","year":"2015","unstructured":"Shibamoto Y, Hashizume C, Baba F, et al. Stereotactic body radiotherapy using a radiobiology-based regimen for stage I non-small-cell lung cancer: five-year mature results. J Thorac Oncol. 2015;10(6):960\u20134. https:\/\/doi.org\/10.1097\/JTO.0000000000000525.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3557_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13014-017-0888-7","volume":"12","author":"A Miyakawa","year":"2017","unstructured":"Miyakawa A, Shibamoto Y, Baba F, et al. Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study. Radiat Oncol. 2017;12(1):152. https:\/\/doi.org\/10.1186\/s13014-017-0888-7.","journal-title":"Radiat Oncol"},{"issue":"10","key":"3557_CR9","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","volume":"22","author":"JY Chang","year":"2021","unstructured":"Chang JY, Mehran RJ, Feng L, et al. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol. 2021;22(10):1448\u201357. https:\/\/doi.org\/10.1016\/S1470-2045(21)00401-0.","journal-title":"Lancet Oncol"},{"issue":"3","key":"3557_CR10","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/j.cllc.2020.04.017","volume":"22","author":"MA Ijsseldijk","year":"2021","unstructured":"Ijsseldijk MA, Shoni M, Siegert C, et al. Oncologic outcomes of surgery versus SBRT for non-small-cell lung carcinoma: a systematic review and meta-analysis. Clin Lung Cancer. 2021;22(3):e235\u201392. https:\/\/doi.org\/10.1016\/j.cllc.2020.04.017.","journal-title":"Clin Lung Cancer"},{"issue":"11","key":"3557_CR11","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.pec.2016.05.017","volume":"99","author":"W Hopmans","year":"2016","unstructured":"Hopmans W, Damman OC, Porsius JT, Zwaan L, Senan S, Timmermans DR. Treatment recommendations by clinicians in stage I non-small cell lung cancer: a study of factors that influence the likelihood of accounting for the patient\u2019s preference. Patient Educ Couns. 2016;99(11):1808\u201313. https:\/\/doi.org\/10.1016\/j.pec.2016.05.017.","journal-title":"Patient Educ Couns"},{"issue":"6","key":"3557_CR12","doi-asserted-by":"publisher","first-page":"5470","DOI":"10.3390\/curroncol30060414","volume":"30","author":"N Panagopoulos","year":"2023","unstructured":"Panagopoulos N, Grapatsas K, Leivaditis V, Galanis M, Dougenis D. Are extensive open lung resections for elderly patients with lung cancer justified? Curr Oncol. 2023;30(6):5470\u201384. https:\/\/doi.org\/10.3390\/curroncol30060414.","journal-title":"Curr Oncol"},{"issue":"4","key":"3557_CR13","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1164\/ajrccm\/139.4.902","volume":"139","author":"J Markos","year":"1989","unstructured":"Markos J, Mullan BP, Hillman DR, et al. Preoperative assessment as a predictor of mortality and morbidity after lung resection. Am Rev Respir Dis. 1989;139(4):902\u201310. https:\/\/doi.org\/10.1164\/ajrccm\/139.4.902.","journal-title":"Am Rev Respir Dis"},{"issue":"6","key":"3557_CR14","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1378\/chest.102.6.1774","volume":"102","author":"DA Holden","year":"1992","unstructured":"Holden DA, Rice TW, Stelmach K, Meeker DP. Exercise testing, 6-min walk, and stair climb in the evaluation of patients at high risk for pulmonary resection. Chest. 1992;102(6):1774\u20139. https:\/\/doi.org\/10.1378\/chest.102.6.1774.","journal-title":"Chest"},{"issue":"5","key":"3557_CR15","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1164\/ajrccm.151.5.7735602","volume":"151","author":"CT Bolliger","year":"1995","unstructured":"Bolliger CT, Jordan P, Sol\u00e8r M, et al. Exercise capacity as a predictor of postoperative complications in lung resection candidates. Am J Respir Crit Care Med. 1995;151(5):1472\u201380. https:\/\/doi.org\/10.1164\/ajrccm.151.5.7735602.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3557_CR16","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1097\/JTO.0b013e31824165d7","volume":"7","author":"M Guckenberger","year":"2012","unstructured":"Guckenberger M, Kestin LL, Hope AJ, et al. Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer? J Thorac Oncol. 2012;7(3):542\u201351. https:\/\/doi.org\/10.1097\/JTO.0b013e31824165d7.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"3557_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1164\/rccm.201207-1299OC","volume":"186","author":"P Lange","year":"2012","unstructured":"Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975\u201381. https:\/\/doi.org\/10.1164\/rccm.201207-1299OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"3557_CR18","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ijrobp.2011.03.005","volume":"82","author":"D Palma","year":"2012","unstructured":"Palma D, Lagerwaard F, Rodrigues G, Haasbeek C, Senan S. Curative treatment of Stage I non-small-cell lung cancer in patients with severe COPD: stereotactic radiotherapy outcomes and systematic review. Int J Radiat Oncol Biol Phys. 2012;82(3):1149\u201356. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.03.005.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3557_CR19","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.radonc.2008.07.019","volume":"88","author":"P Baumann","year":"2008","unstructured":"Baumann P, Nyman J, Hoyer M, et al. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer: a first report of toxicity related to COPD\/CVD in a non-randomized prospective phase II study. Radiother Oncol. 2008;88(3):359\u201367. https:\/\/doi.org\/10.1016\/j.radonc.2008.07.019.","journal-title":"Radiother Oncol"},{"issue":"6","key":"3557_CR20","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/jrr\/rraa075","volume":"61","author":"T Abe","year":"2020","unstructured":"Abe T, Ryuno Y, Saito S, et al. Stereotactic body radiation therapy using CyberKnife for T1N0M0 lung cancer patients with severe pulmonary dysfunction. J Radiat Res. 2020;61(6):903\u20137. https:\/\/doi.org\/10.1093\/jrr\/rraa075.","journal-title":"J Radiat Res"},{"issue":"5","key":"3557_CR21","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383. https:\/\/doi.org\/10.1016\/0021-9681(87)90171-8.","journal-title":"J Chronic Dis"},{"issue":"10","key":"3557_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1056\/NEJMoa021322","volume":"350","author":"BR Celli","year":"2004","unstructured":"Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005\u201312. https:\/\/doi.org\/10.1056\/NEJMoa021322.","journal-title":"N Engl J Med"},{"issue":"3","key":"3557_CR23","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.ijrobp.2017.03.010","volume":"98","author":"H Chen","year":"2017","unstructured":"Chen H, Senan S, Nossent EJ, et al. Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review. Int J Radiat Oncol Biol Phys. 2017;98(3):622\u201331. https:\/\/doi.org\/10.1016\/j.ijrobp.2017.03.010.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"3557_CR24","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jama.2010.261","volume":"303","author":"R Timmerman","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070\u20136. https:\/\/doi.org\/10.1001\/jama.2010.261.","journal-title":"JAMA"},{"issue":"6","key":"3557_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1200\/JCO.2009.25.0928","volume":"28","author":"IS Grills","year":"2010","unstructured":"Grills IS, Mangona VS, Welsh R, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28(6):928\u201335. https:\/\/doi.org\/10.1200\/JCO.2009.25.0928.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3557_CR26","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ijrobp.2012.03.041","volume":"85","author":"R Baker","year":"2013","unstructured":"Baker R, Han G, Sarangkasiri S, et al. Clinical and dosimetric predictors of radiation pneumonitis in a large series of patients treated with stereotactic body radiation therapy to the lung. Int J Radiat Oncol Biol Phys. 2013;85(1):190\u20135. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.03.041.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"3557_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ijrobp.2010.08.056","volume":"82","author":"RB Barriger","year":"2012","unstructured":"Barriger RB, Forquer JA, Brabham JG, et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012;82(1):457\u201362. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.08.056.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"3557_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.radonc.2009.02.003","volume":"91","author":"GR Borst","year":"2009","unstructured":"Borst GR, Ishikawa M, Nijkamp J, et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol. 2009;91(3):307\u201313. https:\/\/doi.org\/10.1016\/j.radonc.2009.02.003.","journal-title":"Radiother Oncol"},{"issue":"4","key":"3557_CR29","doi-asserted-by":"publisher","first-page":"e545","DOI":"10.1016\/j.ijrobp.2012.01.018","volume":"83","author":"Y Matsuo","year":"2012","unstructured":"Matsuo Y, Shibuya K, Nakamura M, et al. Dose\u2013volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2012;83(4):e545\u20139. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.01.018.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3557_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-2-21","author":"H Yamashita","year":"2007","unstructured":"Yamashita H, Nakagawa K, Nakamura N, et al. Exceptionally high incidence of symptomatic grade 2\u20135 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol. 2007. https:\/\/doi.org\/10.1186\/1748-717X-2-21.","journal-title":"Radiat Oncol"},{"issue":"20","key":"3557_CR31","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.1200\/JCO.2008.21.5681","volume":"27","author":"P Baumann","year":"2009","unstructured":"Baumann P, Nyman J, Hoyer M, et al. Outcome in a prospective phase II trial of medically inoperable stage I non-small-cell lung cancer patients treated with stereotactic body radiotherapy. J Clin Oncol. 2009;27(20):3290\u20136. https:\/\/doi.org\/10.1200\/JCO.2008.21.5681.","journal-title":"J Clin Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03557-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03557-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T12:39:34Z","timestamp":1731587974000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03557-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,13]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3557"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03557-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,13]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No disclosure of funding.\u00a0The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Comit\u00e8 \u00c8tic d\u2019Investigaci\u00f3 Cl\u00ednica (CEIC) of Vall d\u2019Hebron University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}